Sarah received her PhD from the University of Manchester where she worked under the supervision of Prof. Nicholas Turner. Following her PhD, she took a position as a Senior Scientist at GlaxoSmithKline where her primary focus was engineering enzymes for use in manufacturing processes. In 2017, she moved back to academia as a BBSRC/MRC Innovation Fellow working in the lab of Dr Anthony Green. As part of this fellowship, she spent time as a visting academic at the University of Washington in the lab of Prof. David Baker, where she learnt to use Rosetta computational algorithms to design enzymes with activities not represented in Nature. In 2020 Sarah was awarded a Presidential Fellowship and UKRI Future Leader Fellowship, allowing her to start her own independent research group. Sarah’s research focusses on the development of versatile biocatalytic approaches for the synthesis of therapeutic oligonucleotides. Her research involves engineering DNA modifying enzymes using directed evolution for applications in oligonucleotide manufacturing.